BORRONI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 26.514
AS - Asia 13.435
EU - Europa 10.938
SA - Sud America 3.589
AF - Africa 286
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 27
Totale 54.821
Nazione #
US - Stati Uniti d'America 26.125
SG - Singapore 4.527
CN - Cina 4.277
BR - Brasile 3.044
UA - Ucraina 2.442
DE - Germania 2.369
HK - Hong Kong 1.901
IT - Italia 1.377
VN - Vietnam 1.045
GB - Regno Unito 868
PL - Polonia 868
RU - Federazione Russa 817
FI - Finlandia 709
TR - Turchia 504
IE - Irlanda 438
FR - Francia 408
IN - India 302
AR - Argentina 236
BD - Bangladesh 196
CA - Canada 166
MX - Messico 142
SE - Svezia 129
IQ - Iraq 104
ZA - Sudafrica 101
NL - Olanda 99
BE - Belgio 98
ID - Indonesia 96
AT - Austria 88
EC - Ecuador 87
JP - Giappone 71
CZ - Repubblica Ceca 61
ES - Italia 58
CO - Colombia 56
PK - Pakistan 56
PY - Paraguay 51
MA - Marocco 49
SA - Arabia Saudita 49
UZ - Uzbekistan 49
VE - Venezuela 39
CL - Cile 34
AU - Australia 28
KE - Kenya 27
EU - Europa 22
IL - Israele 22
KR - Corea 22
LT - Lituania 22
IR - Iran 21
AE - Emirati Arabi Uniti 20
EG - Egitto 20
TN - Tunisia 20
JO - Giordania 19
UY - Uruguay 18
DO - Repubblica Dominicana 17
MU - Mauritius 17
NP - Nepal 17
PE - Perù 17
KZ - Kazakistan 16
AZ - Azerbaigian 15
DZ - Algeria 14
JM - Giamaica 13
BG - Bulgaria 12
LB - Libano 12
RO - Romania 12
TW - Taiwan 11
BH - Bahrain 10
CR - Costa Rica 10
HN - Honduras 10
MY - Malesia 9
PH - Filippine 9
TH - Thailandia 9
PS - Palestinian Territory 8
SN - Senegal 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
EE - Estonia 7
LV - Lettonia 7
BO - Bolivia 6
DK - Danimarca 6
AM - Armenia 5
BB - Barbados 5
CH - Svizzera 5
ET - Etiopia 5
KW - Kuwait 5
NO - Norvegia 5
OM - Oman 5
TT - Trinidad e Tobago 5
XK - ???statistics.table.value.countryCode.XK??? 5
GR - Grecia 4
GT - Guatemala 4
KG - Kirghizistan 4
LK - Sri Lanka 4
NI - Nicaragua 4
PA - Panama 4
RS - Serbia 4
AL - Albania 3
CG - Congo 3
GD - Grenada 3
HR - Croazia 3
HU - Ungheria 3
MN - Mongolia 3
Totale 54.774
Città #
Fairfield 3.708
Woodbridge 2.816
Ashburn 2.162
Singapore 2.126
Houston 1.902
Hong Kong 1.893
Jacksonville 1.771
Seattle 1.464
Cambridge 1.347
Ann Arbor 1.322
Wilmington 1.241
Beijing 934
Warsaw 859
Princeton 786
Nanjing 644
Chandler 626
New York 585
The Dalles 476
Dublin 436
Istanbul 423
Los Angeles 420
Ho Chi Minh City 387
Helsinki 343
Dallas 342
Dearborn 325
Munich 283
São Paulo 270
Nanchang 247
Moscow 239
Des Moines 231
Buffalo 230
Brescia 227
Hanoi 206
Milan 199
Redondo Beach 198
Shenyang 178
Changsha 172
San Diego 171
Shanghai 138
Hebei 135
Chicago 134
Jinan 130
San Francisco 123
Tianjin 112
London 109
Turku 106
Nuremberg 105
Frankfurt am Main 102
Rio de Janeiro 99
Jiaxing 98
Brussels 91
Lancaster 91
Kunming 84
Belo Horizonte 82
Brooklyn 75
Santa Clara 75
Boardman 74
Guangzhou 59
Hangzhou 59
Denver 57
Tokyo 57
Phoenix 55
Toronto 54
Zhengzhou 53
Ningbo 50
Johannesburg 49
Rome 49
Montreal 48
Norwalk 48
Verona 47
San Mateo 45
Tashkent 45
Haiphong 44
Mexico City 42
Nürnberg 42
Curitiba 40
Porto Alegre 40
Dhaka 39
Stockholm 39
Atlanta 38
Brasília 38
Da Nang 37
Taizhou 37
Vienna 37
Orem 36
Romola 36
Baghdad 34
Chennai 34
Salvador 34
Augusta 33
Olomouc 33
Poplar 33
Quito 33
Biên Hòa 32
Boston 32
Charlotte 31
Lanzhou 31
Dong Ket 30
Goiânia 29
Mumbai 29
Totale 35.920
Nome #
[(11)C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis 402
"Alien face" in corticobasal degeneration syndrome: Extending clinical features [2] 310
White matter changes in corticobasal degeneration syndrome and correlation with limb apraxia. 255
Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. 248
The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer's disease. 241
Mutation within TARDBP leads to Frontotemporal Dementia without motor neuron disease. 236
Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia. 229
Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators 217
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 217
COVID-19 impact on consecutive neurological patients admitted to the emergency department 215
Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. 210
Altered brain metabolic connectivity at multiscale level in early Parkinson's disease 209
CSF Alzheimer's disease-like pattern in Corticobasal Syndrome: evidence for a distinct disorder. 208
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 207
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 202
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment 199
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 197
QT dispersion and heart rate variability abnormalities in Alzheimer's disease and in mild cognitive impairment. 196
Action and object naming in frontotemporal dementia, progressive supranuclear palsy, and corticobasal degeneration 194
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 193
A complicated case of intracranial hypotension: Diagnostic and management strategies 192
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 192
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 192
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 188
Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease 187
Extrapyramidal symptoms in Frontotemporal Dementia: prevalence and clinical correlations 186
Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. 184
A case report: doctor, my daughter has Alzheimer's disease. 184
Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic. 183
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease 183
Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia. 180
A complicated case of intracranial hypotension: diagnostic and management strategies. 175
Platelet amyloid precursor protein abnormalities in mild cognitive impairment predict conversion to dementia of Alzheimer type: a 2-year follow-up study. 174
Education plays a different role in Frontotemporal Dementia and Alzheimer's disease 173
TARDBP mutations in frontotemporal lobar degeneration: frequency, clinical features, and disease course. 173
Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation 172
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 170
Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 168
Is early-onset clinicallydifferent from late-onset frontotemporal dementia? 167
Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy 167
EEG and granular osmiophilic elements in early-onset Alzheimer's disease. 167
Autoimmunity and frontotemporal dementia 167
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 165
A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease 164
Functional correlates of Apolipoprotein E genotype in Frontotemporal Lobar Degeneration 164
Functional and structural changes in Alzheimer’s disease and Mild Cognitive Impairment. Possible predictive role of QT Dispersion and Heart Rate Variability analisys 164
A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. 163
The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design 163
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 163
Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. 161
Cognitive and behavioral assessment in the early stages of neurodegenerative extrapyramidalsyndromes 160
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 158
Subcortical and deep cortical atrophy in Frontotemporal Lobar Degeneration. 156
Treatment of primary progressive aphasias by transcranial direct current stimulation combined with language training 156
Choreo-athetosis in LRRK2 R1441C mutation: expanding the clinical phenotype. 156
Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. 155
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 155
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 155
Acombination of CSF tau ratio and midsaggital midbraintopons atrophy for the earlydiagnosis of progressive supranuclear palsy 154
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 154
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 154
A PCR-based protocol to accurately size C9orf72 intermediate-length alleles. 154
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 154
Prefrontal cortex rTMS enhances action naming in Progressive Non-Fluent Aphasia 153
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study 153
Vascular risk factors and cognition in Parkinson's disease 153
Genetic bases of Progressive Supranuclear Palsy: the MAPT tau disease. 152
Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD 152
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 151
The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is not significantly correlated to Transient Global Amnesia: preliminary results of an on-going study in Brescia Province, Italy. 150
Two Sequential Tc-99m ECD SPECT Studies in a Case of Sporadic Creutzfeldt–Jakob Disease Confirmed at Autopsy 150
Serum C-Peptide, Visfatin, Resistin, and Ghrelin are Altered in Sporadic and GRN-Associated Frontotemporal Lobar Degeneration 150
Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy. 149
Cardiac arrhythmias and silent myocardial ischaemia in Mild Cognitive Impairment and Alzheimer Disease 148
Early maturation and distinct tau pathology in induced pluripotent stem cell-derived neurons from patients with MAPT mutations. 148
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38. 147
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 147
The Speech and Language FOXP2 GeneModulates the Phenotype of Frontotemporal Lobar Degeneration 146
APOE genotype and cholesterol levels in lewy body dementia and Alzheimer disease: investigating genotype-phenotype effect on disease risk 145
Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates 145
Serum leptin levels are higher in females affected by frontotemporal lobar degeneration than Alzheimer's disease 144
Advances on biological markers in early diagnosis of Alzheimer disease 144
Left parietal cortex transcranial direct current stimulation enhances gesture processing in corticobasal syndrome. 143
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 143
Association between tau H2 haplotype and age at onset in frontotemporal dementia 142
Beyond cognitive reserve: behavioural reserve hypothesis in Frontotemporal Dementia. 142
Anodal transcranial direct current stimulation of parietal cortex enhances action naming in Corticobasal Syndrome. 141
Behavioral dimensions and acetylcholinesterase inhibitor-related effect in Alzheimer disease over time: a latent trajectory modeling. 140
Clinical, biological, and imaging features of monogenic Alzheimer's Disease. 140
Understanding Emotions in Frontotemporal Dementia: The Explicit and Implicit Emotional Cue Mismatch. 140
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia. 140
Natural history and predictors of survival in progressive supranuclear palsy. 140
Endothelial nitric oxide synthase polymorphisms as risk factors for migraine: a response. 139
Familial aggregation in Progressive Supranuclear Palsy and Corticobasal Syndrome. 139
Pattern ofbehavioral disturbances in corticobasal degeneration syndrome and progressivesupranuclear palsy 139
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series. 139
Cardiovascular structural and functional changes in Mild Cognitive Impairment and Alzheimer Disease.Potential predictive role of QT Dispersion and Heart Rate Variability Analysis 138
ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects. 138
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. 138
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 138
Totale 17.183
Categoria #
all - tutte 275.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 275.293


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.001 0 0 0 0 0 680 245 720 784 617 698 257
2021/20223.171 213 539 69 148 29 162 228 236 190 416 280 661
2022/20232.442 448 115 63 152 155 675 24 171 273 71 171 124
2023/20243.243 169 72 289 209 107 499 111 117 950 65 58 597
2024/20259.056 79 50 88 1.262 1.015 729 824 255 934 775 1.835 1.210
2025/202611.787 1.720 2.801 1.735 3.089 1.415 1.027 0 0 0 0 0 0
Totale 55.599